SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-20-004715
Filing Date
2020-01-16
Accepted
2020-01-16 15:55:26
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 tm203484-4_425.htm 425 14914
2 GRAPHIC tm203484-4_425img001.jpg GRAPHIC 94951
3 GRAPHIC tm203484-4_425img002.jpg GRAPHIC 110193
4 GRAPHIC tm203484-4_425img003.jpg GRAPHIC 139091
5 GRAPHIC tm203484-4_425img004.jpg GRAPHIC 93417
6 GRAPHIC tm203484-4_425img005.jpg GRAPHIC 74402
7 GRAPHIC tm203484-4_425img006.jpg GRAPHIC 88680
  Complete submission text file 0001104659-20-004715.txt   841050
Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Filed by) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Subject) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38551 | Film No.: 20530851
SIC: 2836 Biological Products, (No Diagnostic Substances)